Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pandion Therapeutics
Biotech
Insider trading off Merck-Pandion deal was family affair: SEC
New details allege that one of the two men charged in an insider trading scheme related to Merck's Pandion deal gave intel to his brother.
Max Bayer
Nov 11, 2022 10:45am
SEC charges 2 with insider trading over Merck-Pandion deal
Jul 26, 2022 5:30am
Seismic, padded by ex-Pandion C-suite, unveils with $101M
Feb 9, 2022 7:00am
Versant nets $950M to build its next class of biotech startups
Apr 21, 2021 8:55am
How Pandion went from a $65M Merck offer to a $1.9B done deal
Mar 5, 2021 9:09am
Merck inks $2B buyout to go up against Amgen, Lilly and Roche
Feb 25, 2021 8:50am
